Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma

Kristina Y. Aguilera, Lee B. Rivera, Hoon Hur, Juliet G. Carbon, Jason E. Toombs, Courtney D. Goldstein, Michael T. Dellinger, Diego H. Castrillon, Rolf A. Brekken

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

There is growing evidence that antiangiogenic therapy stimulates cancer cell invasion and metastasis. However, the underlying molecular mechanisms responsible for these changes have not been fully defined. Here, we report that anti-VEGF therapy promotes local invasion and metastasis by inducing collagen signaling in cancer cells. We show that chronic VEGF inhibition in a genetically engineered mouse model of pancreatic ductal adenocarcinoma (PDA) induces hypoxia, a less differentiated mesenchymal-like tumor cell phenotype, TGF-β expression, and collagen deposition and signaling. In addition, we showthat collagen signaling is critical for protumorigenic activity of TGF-β in vitro. To further model the impact of collagen signaling in tumors, we evaluated PDA in mice lacking Sparc, a protein that reduces collagen binding to cell surface receptors. Importantly, we show that loss of Sparc increases collagen signaling and tumor progression. Together, these findings suggest that collagen actively promotes PDA spread and that enhanced disease progression associated with anti-VEGF therapy can arise from elevated extracellular matrix-mediated signaling.

Original languageEnglish (US)
Pages (from-to)1032-1044
Number of pages13
JournalCancer Research
Volume74
Issue number4
DOIs
StatePublished - Feb 15 2014

Fingerprint

Vascular Endothelial Growth Factor A
Adenocarcinoma
Collagen
Neoplasms
Therapeutics
Neoplasm Metastasis
Cell Surface Receptors
Extracellular Matrix
Disease Progression
Phenotype
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. / Aguilera, Kristina Y.; Rivera, Lee B.; Hur, Hoon; Carbon, Juliet G.; Toombs, Jason E.; Goldstein, Courtney D.; Dellinger, Michael T.; Castrillon, Diego H.; Brekken, Rolf A.

In: Cancer Research, Vol. 74, No. 4, 15.02.2014, p. 1032-1044.

Research output: Contribution to journalArticle

Aguilera, Kristina Y. ; Rivera, Lee B. ; Hur, Hoon ; Carbon, Juliet G. ; Toombs, Jason E. ; Goldstein, Courtney D. ; Dellinger, Michael T. ; Castrillon, Diego H. ; Brekken, Rolf A. / Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. In: Cancer Research. 2014 ; Vol. 74, No. 4. pp. 1032-1044.
@article{f355bd0b92774fe2a5749da342162d3c,
title = "Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma",
abstract = "There is growing evidence that antiangiogenic therapy stimulates cancer cell invasion and metastasis. However, the underlying molecular mechanisms responsible for these changes have not been fully defined. Here, we report that anti-VEGF therapy promotes local invasion and metastasis by inducing collagen signaling in cancer cells. We show that chronic VEGF inhibition in a genetically engineered mouse model of pancreatic ductal adenocarcinoma (PDA) induces hypoxia, a less differentiated mesenchymal-like tumor cell phenotype, TGF-β expression, and collagen deposition and signaling. In addition, we showthat collagen signaling is critical for protumorigenic activity of TGF-β in vitro. To further model the impact of collagen signaling in tumors, we evaluated PDA in mice lacking Sparc, a protein that reduces collagen binding to cell surface receptors. Importantly, we show that loss of Sparc increases collagen signaling and tumor progression. Together, these findings suggest that collagen actively promotes PDA spread and that enhanced disease progression associated with anti-VEGF therapy can arise from elevated extracellular matrix-mediated signaling.",
author = "Aguilera, {Kristina Y.} and Rivera, {Lee B.} and Hoon Hur and Carbon, {Juliet G.} and Toombs, {Jason E.} and Goldstein, {Courtney D.} and Dellinger, {Michael T.} and Castrillon, {Diego H.} and Brekken, {Rolf A.}",
year = "2014",
month = "2",
day = "15",
doi = "10.1158/0008-5472.CAN-13-2800",
language = "English (US)",
volume = "74",
pages = "1032--1044",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma

AU - Aguilera, Kristina Y.

AU - Rivera, Lee B.

AU - Hur, Hoon

AU - Carbon, Juliet G.

AU - Toombs, Jason E.

AU - Goldstein, Courtney D.

AU - Dellinger, Michael T.

AU - Castrillon, Diego H.

AU - Brekken, Rolf A.

PY - 2014/2/15

Y1 - 2014/2/15

N2 - There is growing evidence that antiangiogenic therapy stimulates cancer cell invasion and metastasis. However, the underlying molecular mechanisms responsible for these changes have not been fully defined. Here, we report that anti-VEGF therapy promotes local invasion and metastasis by inducing collagen signaling in cancer cells. We show that chronic VEGF inhibition in a genetically engineered mouse model of pancreatic ductal adenocarcinoma (PDA) induces hypoxia, a less differentiated mesenchymal-like tumor cell phenotype, TGF-β expression, and collagen deposition and signaling. In addition, we showthat collagen signaling is critical for protumorigenic activity of TGF-β in vitro. To further model the impact of collagen signaling in tumors, we evaluated PDA in mice lacking Sparc, a protein that reduces collagen binding to cell surface receptors. Importantly, we show that loss of Sparc increases collagen signaling and tumor progression. Together, these findings suggest that collagen actively promotes PDA spread and that enhanced disease progression associated with anti-VEGF therapy can arise from elevated extracellular matrix-mediated signaling.

AB - There is growing evidence that antiangiogenic therapy stimulates cancer cell invasion and metastasis. However, the underlying molecular mechanisms responsible for these changes have not been fully defined. Here, we report that anti-VEGF therapy promotes local invasion and metastasis by inducing collagen signaling in cancer cells. We show that chronic VEGF inhibition in a genetically engineered mouse model of pancreatic ductal adenocarcinoma (PDA) induces hypoxia, a less differentiated mesenchymal-like tumor cell phenotype, TGF-β expression, and collagen deposition and signaling. In addition, we showthat collagen signaling is critical for protumorigenic activity of TGF-β in vitro. To further model the impact of collagen signaling in tumors, we evaluated PDA in mice lacking Sparc, a protein that reduces collagen binding to cell surface receptors. Importantly, we show that loss of Sparc increases collagen signaling and tumor progression. Together, these findings suggest that collagen actively promotes PDA spread and that enhanced disease progression associated with anti-VEGF therapy can arise from elevated extracellular matrix-mediated signaling.

UR - http://www.scopus.com/inward/record.url?scp=84894277482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894277482&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-2800

DO - 10.1158/0008-5472.CAN-13-2800

M3 - Article

C2 - 24346431

AN - SCOPUS:84894277482

VL - 74

SP - 1032

EP - 1044

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 4

ER -